Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-9-30
pubmed:abstractText
Tie2 receptor is a receptor tyrosine kinase that plays important roles in vascular angiogenesis, and also highly expressed by a number of cancer cells. In this study, we reported an active targeting liposome system directed by a novel peptide ligand PH1 that can improve drug efficacies specifically to Tie2 expressing cells. The PH1 peptide (TMGFTAPRFPHY) was selected by phage display library screening combined with surface plasmon resonance binding assays. It was covalently conjugated to the distal end of DSPE-PEG(2000)-Maleimide lipid and loaded onto liposome membranes as the targeting ligand. These PH1-PEG-liposomes containing the anticancer drug cisplatin were showed to bind tightly to Tie2 positive cells, mediate active endocytosis of the drug containing liposomes, and result in much higher cell specific cytoxicities than mPEG coated liposomes. They can be used not only to target vascular endothelial cells for anti-angiogenesis effects, but also to improve drug delivery and release in Tie2 expressing cancer cells. Such liposome formulation may be developed into a very useful agent for metronomic chemotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1873-4995
pubmed:author
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
139
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
174-81
pubmed:meshHeading
pubmed-meshheading:19576253-Antineoplastic Agents, pubmed-meshheading:19576253-Cell Line, Tumor, pubmed-meshheading:19576253-Cell Survival, pubmed-meshheading:19576253-Chemistry, Pharmaceutical, pubmed-meshheading:19576253-Cisplatin, pubmed-meshheading:19576253-Dose-Response Relationship, Drug, pubmed-meshheading:19576253-Drug Carriers, pubmed-meshheading:19576253-Drug Compounding, pubmed-meshheading:19576253-Endocytosis, pubmed-meshheading:19576253-Endothelial Cells, pubmed-meshheading:19576253-Humans, pubmed-meshheading:19576253-Inhibitory Concentration 50, pubmed-meshheading:19576253-Liposomes, pubmed-meshheading:19576253-Maleimides, pubmed-meshheading:19576253-Neoplasms, pubmed-meshheading:19576253-Oligopeptides, pubmed-meshheading:19576253-Peptide Library, pubmed-meshheading:19576253-Phosphatidylethanolamines, pubmed-meshheading:19576253-Polyethylene Glycols, pubmed-meshheading:19576253-Receptor, TIE-2, pubmed-meshheading:19576253-Surface Plasmon Resonance, pubmed-meshheading:19576253-Time Factors
pubmed:year
2009
pubmed:articleTitle
A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
pubmed:affiliation
School of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, PR China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't